Cargando…

The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study

Objective To determine rates of major bleeding by level of kidney function for older adults with atrial fibrillation starting warfarin. Design Retrospective cohort study. Setting Community based, using province wide laboratory and administrative data in Alberta, Canada. Participants 12 403 adults ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Min, James, Matthew T, Manns, Braden J, Quinn, Robert R, Ravani, Pietro, Tonelli, Marcello, Perkovic, Vlado, Winkelmayer, Wolfgang C, Ma, Zhihai, Hemmelgarn, Brenda R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169066/
https://www.ncbi.nlm.nih.gov/pubmed/25647223
http://dx.doi.org/10.1136/bmj.h246
_version_ 1783360451026878464
author Jun, Min
James, Matthew T
Manns, Braden J
Quinn, Robert R
Ravani, Pietro
Tonelli, Marcello
Perkovic, Vlado
Winkelmayer, Wolfgang C
Ma, Zhihai
Hemmelgarn, Brenda R
author_facet Jun, Min
James, Matthew T
Manns, Braden J
Quinn, Robert R
Ravani, Pietro
Tonelli, Marcello
Perkovic, Vlado
Winkelmayer, Wolfgang C
Ma, Zhihai
Hemmelgarn, Brenda R
author_sort Jun, Min
collection PubMed
description Objective To determine rates of major bleeding by level of kidney function for older adults with atrial fibrillation starting warfarin. Design Retrospective cohort study. Setting Community based, using province wide laboratory and administrative data in Alberta, Canada. Participants 12 403 adults aged 66 years or more, with atrial fibrillation who started warfarin treatment between 1 May 2003 and 31 March 2010 and had a measure of kidney function at baseline. Kidney function was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation and participants were categorised based on estimated glomerular filtration rate (eGFR): ≥90, 60-89, 45-59, 30-44, 15-29, <15 mL/min/1.73m(2). We excluded participants with end stage renal disease (dialysis or renal transplant) at baseline. Main outcome measures Admission to hospital or visit to an emergency department for major bleeding (intracranial, upper and lower gastrointestinal, or other). Results Of 12 403 participants, 45% had an eGFR <60 mL/min/1.73m(2). Overall, 1443 (11.6%) experienced a major bleeding episode over a median follow-up of 2.1 (interquartile range: 1.0-3.8) years. During the first 30 days of warfarin treatment, unadjusted and adjusted rates of major bleeding were higher at lower eGFR (P for trend <0.001 and 0.001, respectively). Adjusted bleeding rates per 100 person years were 63.4 (95% confidence interval 24.9 to 161.6) in participants with eGFR <15 mL/min/1.73m(2) compared with 6.1 (1.9 to 19.4) among those with eGFR >90 mL/min/1.73m(2) (adjusted incidence rate ratio 10.3, 95% confidence interval 2.3 to 45.5). Similar associations were observed at more than 30 days after starting warfarin, although the magnitude of the increase in rates across eGFR categories was attenuated. Across all eGFR categories, adjusted rates of major bleeding were consistently higher during the first 30 days of warfarin treatment compared with the remainder of follow-up. Increases in major bleeding rates were largely due to gastrointestinal bleeding (3.5-fold greater in eGFR <15 mL/min/1.73m(2) compared with ≥90 mL/min/1.73m(2)). Intracranial bleeding was not increased with worsening kidney function. Conclusions Reduced kidney function was associated with an increased risk of major bleeding among older adults with atrial fibrillation starting warfarin; excess risks from reduced eGFR were most pronounced during the first 30 days of treatment. Our results support the need for careful consideration of the bleeding risk relative to kidney function when assessing the risk-benefit ratio of warfarin treatment in people with chronic kidney disease and atrial fibrillation, particularly in the first 30 days of treatment.
format Online
Article
Text
id pubmed-6169066
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-61690662018-10-10 The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study Jun, Min James, Matthew T Manns, Braden J Quinn, Robert R Ravani, Pietro Tonelli, Marcello Perkovic, Vlado Winkelmayer, Wolfgang C Ma, Zhihai Hemmelgarn, Brenda R BMJ Research Objective To determine rates of major bleeding by level of kidney function for older adults with atrial fibrillation starting warfarin. Design Retrospective cohort study. Setting Community based, using province wide laboratory and administrative data in Alberta, Canada. Participants 12 403 adults aged 66 years or more, with atrial fibrillation who started warfarin treatment between 1 May 2003 and 31 March 2010 and had a measure of kidney function at baseline. Kidney function was estimated using the Chronic Kidney Disease Epidemiology Collaboration equation and participants were categorised based on estimated glomerular filtration rate (eGFR): ≥90, 60-89, 45-59, 30-44, 15-29, <15 mL/min/1.73m(2). We excluded participants with end stage renal disease (dialysis or renal transplant) at baseline. Main outcome measures Admission to hospital or visit to an emergency department for major bleeding (intracranial, upper and lower gastrointestinal, or other). Results Of 12 403 participants, 45% had an eGFR <60 mL/min/1.73m(2). Overall, 1443 (11.6%) experienced a major bleeding episode over a median follow-up of 2.1 (interquartile range: 1.0-3.8) years. During the first 30 days of warfarin treatment, unadjusted and adjusted rates of major bleeding were higher at lower eGFR (P for trend <0.001 and 0.001, respectively). Adjusted bleeding rates per 100 person years were 63.4 (95% confidence interval 24.9 to 161.6) in participants with eGFR <15 mL/min/1.73m(2) compared with 6.1 (1.9 to 19.4) among those with eGFR >90 mL/min/1.73m(2) (adjusted incidence rate ratio 10.3, 95% confidence interval 2.3 to 45.5). Similar associations were observed at more than 30 days after starting warfarin, although the magnitude of the increase in rates across eGFR categories was attenuated. Across all eGFR categories, adjusted rates of major bleeding were consistently higher during the first 30 days of warfarin treatment compared with the remainder of follow-up. Increases in major bleeding rates were largely due to gastrointestinal bleeding (3.5-fold greater in eGFR <15 mL/min/1.73m(2) compared with ≥90 mL/min/1.73m(2)). Intracranial bleeding was not increased with worsening kidney function. Conclusions Reduced kidney function was associated with an increased risk of major bleeding among older adults with atrial fibrillation starting warfarin; excess risks from reduced eGFR were most pronounced during the first 30 days of treatment. Our results support the need for careful consideration of the bleeding risk relative to kidney function when assessing the risk-benefit ratio of warfarin treatment in people with chronic kidney disease and atrial fibrillation, particularly in the first 30 days of treatment. BMJ Publishing Group Ltd. 2015-02-03 /pmc/articles/PMC6169066/ /pubmed/25647223 http://dx.doi.org/10.1136/bmj.h246 Text en © Jun et al 2015 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Jun, Min
James, Matthew T
Manns, Braden J
Quinn, Robert R
Ravani, Pietro
Tonelli, Marcello
Perkovic, Vlado
Winkelmayer, Wolfgang C
Ma, Zhihai
Hemmelgarn, Brenda R
The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title_full The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title_fullStr The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title_full_unstemmed The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title_short The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
title_sort association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169066/
https://www.ncbi.nlm.nih.gov/pubmed/25647223
http://dx.doi.org/10.1136/bmj.h246
work_keys_str_mv AT junmin theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT jamesmatthewt theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT mannsbradenj theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT quinnrobertr theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT ravanipietro theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT tonellimarcello theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT perkovicvlado theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT winkelmayerwolfgangc theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT mazhihai theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT hemmelgarnbrendar theassociationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT junmin associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT jamesmatthewt associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT mannsbradenj associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT quinnrobertr associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT ravanipietro associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT tonellimarcello associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT perkovicvlado associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT winkelmayerwolfgangc associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT mazhihai associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy
AT hemmelgarnbrendar associationbetweenkidneyfunctionandmajorbleedinginolderadultswithatrialfibrillationstartingwarfarintreatmentpopulationbasedobservationalstudy